SCHEMBL4594825

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL14086490	1.00	AR (0.74)	ARPGRS1PR1UBE2MDCUN1D1
	SCHEMBL4595431	0.89	AR (0.61)	ARPGRS1PR1UBE2MDCUN1D1
	SCHEMBL3288953	0.86	AR (1.00)	ARPGRS1PR1
	SCHEMBL3288957	0.86	AR (1.00)	ARPGRS1PR1
	SCHEMBL4604860	0.84	AR (0.84)	ARPGRS1PR1
	SCHEMBL4604858	0.84	AR (0.84)	ARPGRS1PR1
	SCHEMBL4903771	0.83	AR (0.82)	ARPGRS1PR1
	SCHEMBL4595949	0.83	AR (0.82)	ARPGRS1PR1
	SCHEMBL14086486	0.83	AR (0.82)	ARPGRS1PR1
	SCHEMBL4903768	0.83	AR (0.82)	ARPGRS1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.